The French laboratory Sanofi, will invest € 610 million in France, in particular, to create a new site of production of vaccines, he announced on Tuesday on the occasion of the visit of the president and Emmanuel Macron in one of its factories in the lyon region.
also Read Vaccines Covid-19 : "You must not sell the skin of the bear before having killed him"
The group will invest nearly half a billion euros in a new plant in Neuville-sur-Saone in lyon region, to create its " Evolutive Vaccine Facility." This new site "will appeal to the most innovative technologies in the field of vaccine production," said the lab, which adds that this investment of 490 million euros over five years is expected to create 200 new jobs.
€ 120 million for a new research centre
" The investment that you just advertise, this is a great trait of union between the two acts of the battle that we have to drive ", said Emmanuel Macron on Tuesday, during a press conference on the site of Sanofi Marcy-L'etoile, evoking the health crisis recedes and the economic crisis that started.
also Read Vaccine against the Covid-19 : words of guinea pigs
" The project announced today is to put Sanofi and France at the excellence of the fight against the virus ", he added. Will add to this investment of 120 million euros to create a new research and development centre on the site of Sanofi Pasteur in Marcy-l'étoile. This complex will be devoted to the development of vaccines against emerging diseases and the risks a pandemic.
Sanofi, which is one of the main global players in the production of vaccines, is currently working on the development of two vaccines against the Covid-19, expected in 2021. The group had created controversy last month, when its director-general Paul Hudson had referred to the possibility of fostering the United States, which have invested in the search for vaccines against the coronavirus.Updated Date: 16 June 2020, 08:33